Bain Capital Private Equity
Bain Capital Private Equity pioneered the value-added investment approach.
Business Model:
Revenue: $170M
Employees: 201-500
Rankings
Industries / Tags:
Detailed Bain Capital Private Equity Information
Geographic Data
Address: 200 Clarendon Street
City: Boston
State: MA
Zip: 02116
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Twitter
Linkedin
Crunchbase
Metrics
1,902,490Website Global Rank
11,425Website Monthly Traffic
Twitter Followers
Description
Bain Capital Private Equity pioneered the value-added investment approach. Their globally integrated teams leverage deep vertical expertise and partner with management teams around the world to accelerate growth.
Contact Phone:
+16175162000
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 8/2022 | Virgin Voyages | Private Equity Round | 550M |
| 10/2022 | CitiusTech | Private Equity Round | - |
| 8/2020 | Nutanix | Post-IPO Debt | 0 |
| 3/2021 | Newlinks Technology | Private Equity Round | 0 |
| 10/2020 | Advantage Solutions | Post-IPO Equity | 0 |
| 10/2018 | Cerevel Therapeutics | Private Equity Round | 0 |
| 2/2022 | EcoCeres | Series A | 108M |
| 1/2019 | Brillio | Private Equity Round | - |
| 1/2018 | QuVa Pharma | Equity | 15M |
| 4/2021 | pulseData | Series A | 0 |
| 8/2017 | STADA Arzneimittel AG | Private Equity Round | - |
| 4/2021 | pulseData | Series A | 0 |
| 3/2021 | Newlinks Technology | Private Equity Round | 0 |
| 10/2020 | Advantage Solutions | Post-IPO Equity | 0 |
| 8/2020 | Nutanix | Post-IPO Debt | 0 |
| 1/2019 | Brillio | Private Equity Round | - |
| 10/2018 | Cerevel Therapeutics | Private Equity Round | 0 |
| 1/2018 | QuVa Pharma | Private Equity Round | 0 |
| 8/2017 | STADA Arzneimittel AG | Private Equity Round | - |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
